News & events - Fortimedix Surgical

Fortimedix Surgical at SAGES 2016

Fortimedix Surgical is at SAGES again this year! Surgeons can visit us at booth #1122 on the exhibition floor to try out the FMX314 Surgical Platform and experience all of its features first-hand.

Read the full article

510(k) Submission with FDA for FMX314 Surgical Platform

Fortimedix Surgical announced today that it has submitted a premarket notification for the FMX314 Surgical Platform with the US Food and Drug Administration (FDA), under Section 510(k) of the Food, Drug and Cosmetic Act.

Read the full article

Participation SAGES 2015

As part of the pre-commercial marketing effort for our novel platform for single-incision laparoscopic surgery FMX314, Fortimedix Surgical B.V. successfully exhibited at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2015 Annual Meeting (April 15-18) in Nashville, Tennessee.

Read the full article

Note: FMX314 is the engineering code name for symphonX™ used during the pre-commercial phase.

For media inquiries, please contact Marc van de Graaf via +1(858) 414 4989 or via our media(at)fortimedix.com

Stay updated about the latest developments and innovations from Fortimedix Surgical - subscribe to our newsletter via our subscription form.